Search - tctmd.com

Displaying 381 - 400 of 807

Sort: Relevancy | Date

News Daily News

La Revascularización Incompleta se asocia a Peores Resultados en Pacientes TAVR con EAC

September 11, 2014

News Daily News

Incomplete Revascularization Linked to Poorer Outcomes in TAVR Patients With CAD

September 11, 2014

News Industry News

Medtronic Announces First U.S. Implants in Clinical Study of Recapturable CoreValve Evolut R

September 10, 2014

News Industry News

Boston Scientific Announces Schedule For Presentations At Upcoming TCT 2014

September 10, 2014

News Conference News ESC 2014

ESC Congress 2014: Positive, Negative Findings Come on Background of Improving Outcomes Overall

Todd Neale

September 08, 2014

Presentation ESC 2014

Is TAVR the treatment of choice for high risk diabetic patients with aortic stenosis? Insights from the FRANCE2 Registry

Presenter: Eric Van Belle

September 02, 2014

News Conference News ESC 2014

FRANCE2: Registry Shows Positive Outcomes for TAVR in High-Risk Diabetic Patients

Yael L. Maxwell

September 02, 2014

News Daily News

Assessing Aortic Valve Calcification May Help Predict Paravalvular Leak After TAVR

Yael L. Maxwell

September 02, 2014

News Conference News ESC 2014

Single-Center Study Compares TAVR Devices in Mixed Aortic Stenosis

Caitlin E. Cox

August 31, 2014

News Conference News ESC 2014

Registry Outcomes Match Positive Trial Findings for Repositionable TAVR Device

Todd Neale

August 31, 2014

News Daily News

GARY: Majority of Patients Do Well With TAVR or Surgery at 1 Year

L.A. McKeown

August 20, 2014

News Industry News

Minneapolis Heart Institute Foundation Announces Its First Implant of Portico Aortic Heart Valve System

August 18, 2014

News Daily News

Proximal May Be Preferred Form of Embolic Protection in Carotid Stenting

August 07, 2014

News Daily News

Prior Renal Impairment, Low Body Weight Predispose to Acute Kidney Injury After TAVR

August 07, 2014

News Daily News

New CMR-Identified Myocardial Injury Post-TAVR Linked With Decreased LV Function

Yael L. Maxwell

July 24, 2014

News Industry News

Results of first-in-human study of Transcatheter Technologies’ TAVI device, TRINITY, are reported in(1)

July 22, 2014

News Industry News

Results of first-in-human study of Transcatheter Technologies’ TAVI device, TRINITY, are reported in EuroIntervention

July 22, 2014

News Daily News

PARTNER Analyses Highlight Mortality Curves After TAVR

Caitlin E. Cox

July 17, 2014

News Industry News

Boston Scientific Receives CE Mark For The New 25 mm Lotus™ Valve System

July 14, 2014

News Daily News

患者特征可预测TAVR后的永久起搏器需求

Yael L. Maxwell

July 10, 2014

Advertisement

La Revascularización Incompleta se asocia a Peores Resultados en Pacientes TAVR con EAC

Incomplete Revascularization Linked to Poorer Outcomes in TAVR Patients With CAD

Medtronic Announces First U.S. Implants in Clinical Study of Recapturable CoreValve Evolut R

Boston Scientific Announces Schedule For Presentations At Upcoming TCT 2014

ESC Congress 2014: Positive, Negative Findings Come on Background of Improving Outcomes Overall

Is TAVR the treatment of choice for high risk diabetic patients with aortic stenosis? Insights from the FRANCE2 Registry

FRANCE2: Registry Shows Positive Outcomes for TAVR in High-Risk Diabetic Patients

Assessing Aortic Valve Calcification May Help Predict Paravalvular Leak After TAVR

Single-Center Study Compares TAVR Devices in Mixed Aortic Stenosis

Registry Outcomes Match Positive Trial Findings for Repositionable TAVR Device

GARY: Majority of Patients Do Well With TAVR or Surgery at 1 Year

Minneapolis Heart Institute Foundation Announces Its First Implant of Portico Aortic Heart Valve System

Proximal May Be Preferred Form of Embolic Protection in Carotid Stenting

Prior Renal Impairment, Low Body Weight Predispose to Acute Kidney Injury After TAVR

New CMR-Identified Myocardial Injury Post-TAVR Linked With Decreased LV Function

Results of first-in-human study of Transcatheter Technologies’ TAVI device, TRINITY, are reported in(1)

Results of first-in-human study of Transcatheter Technologies’ TAVI device, TRINITY, are reported in EuroIntervention

PARTNER Analyses Highlight Mortality Curves After TAVR

Boston Scientific Receives CE Mark For The New 25 mm Lotus™ Valve System

患者特征可预测TAVR后的永久起搏器需求

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content